{"id":310597,"date":"2019-12-19T21:58:07","date_gmt":"2019-12-20T05:58:07","guid":{"rendered":"https:\/\/nai500.com\/blog\/2019\/12\/healthcare-roundup-amgen-files-us-application-for-rituxan-biosimilar-gilead-files-us-application-for-filgotinib\/"},"modified":"2019-12-19T21:58:26","modified_gmt":"2019-12-20T05:58:26","slug":"%e5%8c%bb%e7%96%97%e4%bf%9d%e5%81%a5%e7%b2%be%e9%80%89%e5%ae%89%e8%bf%9b%e6%8f%90%e4%ba%a4%e7%be%8e%e5%9b%bd-rituxan-%e7%94%9f%e7%89%a9%e4%bb%bf%e5%88%b6%e8%8d%af%e7%9a%84%e7%94%b3%e8%af%b7%e5%90%89","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hans\/blog\/2019\/12\/%e5%8c%bb%e7%96%97%e4%bf%9d%e5%81%a5%e7%b2%be%e9%80%89%e5%ae%89%e8%bf%9b%e6%8f%90%e4%ba%a4%e7%be%8e%e5%9b%bd-rituxan-%e7%94%9f%e7%89%a9%e4%bb%bf%e5%88%b6%e8%8d%af%e7%9a%84%e7%94%b3%e8%af%b7%e5%90%89\/","title":{"rendered":"\u533b\u7597\u4fdd\u5065\u7cbe\u9009\u2014\u2014\u5b89\u8fdb\u63d0\u4ea4\u7f8e\u56fdRituxan\u751f\u7269\u4eff\u5236\u836f\u7684\u7533\u8bf7\uff0c\u5409\u5229\u5fb7\u63d0\u4ea4\u7f8e\u56fdfilgotinib\u7533\u8bf7"},"content":{"rendered":"<h2>\u5b89\u8fdb\u516c\u53f8\u5728\u7f8e\u56fd\u63d0\u4ea4Rituxan\u751f\u7269\u4eff\u5236\u836f\u7533\u8bf7<\/h2>\n<p><a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=AMGN\">\u5b89\u8fdb (NASDAQ:AMGN)<\/a>\u5df2\u5411FDA\u63d0\u4ea4\u4e86\u4e00\u4efd\u8425\u9500\u7533\u8bf7\uff0c\u4ee5\u5bfb\u6c42AMG 798\u7684\u6279\u51c6\uff0c\u8be5\u4ea7\u54c1\u662f\u7f57\u6c0f\uff08OTCQX\uff1aRHHBY\uff09Rituxan\uff08rituximab\uff09\u7684\u751f\u7269\u4eff\u5236\u836f\u3002<\/p>\n<p>\u5b89\u8fdb\u6b63\u5728\u4e0e<a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=AGN\">\u827e\u5c14\u5065\uff08NYSE\uff1aAGN\uff09<\/a>\u5408\u4f5c\u5f00\u53d1\u56db\u79cd\u751f\u7269\u4eff\u5236\u836f\uff0c\u5176\u4e2d\u4e24\u79cd\u5728\u7f8e\u56fd\u83b7\u5f97\u6279\u51c6\u3002\u5b89\u8fdb\u4e3b\u8981\u8d1f\u8d23\u5f00\u53d1\u3001\u5236\u9020\u548c\u521d\u59cb\u5546\u4e1a\u5316\u3002<\/p>\n<h2>\u5409\u5229\u5fb7\u63d0\u4ea4filgotinib\u6cbb\u7597\u7c7b\u98ce\u6e7f\u5173\u8282\u708e\u7684\u7533\u8bf7<\/h2>\n<p><a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=GILD\">\u5409\u5229\u5fb7\u79d1\u5b66\u516c\u53f8(NASDAQ:GILD)<\/a>\u5df2\u5411FDA\u63d0\u4ea4\u4e86\u8425\u9500\u7533\u8bf7\uff0c\u4ee5\u5bfb\u6c42\u6279\u51c6filgotinib\u7528\u4e8e\u4e2d\u91cd\u5ea6\u7c7b\u98ce\u6e7f\u5173\u8282\u708e\u60a3\u8005\u3002<\/p>\n<p>\u5409\u5229\u5fb7\u63d0\u4ea4\u4e86\u5e26\u6709\u4f18\u5148\u5ba1\u67e5\u51ed\u8bc1\u7684\u7533\u8bf7\uff0c\u5982\u679c\u8be5\u673a\u6784\u63a5\u53d7\uff0c\u5219\u53ef\u4ee5\u5c06\u5ba1\u67e5\u65f6\u95f4\u7f29\u77ed\u81f3\u516d\u4e2a\u6708\u3002<\/p>\n<p>\u6839\u636e2015\u5e74\u7684\u534f\u8bae\uff0c\u5409\u5229\u5fb7\u5c06\u4e0e<a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=GIPG\">Galapagos NV\uff08NASDAQ\uff1aGLPG\uff09<\/a>\u5171\u540c\u5f00\u53d1JAK1\u6291\u5236\u5242\u5e76\u5c06\u5176\u5546\u4e1a\u5316\u3002\u8be5\u6587\u4ef6\u89e6\u53d1\u4e86\u5409\u5229\u5fb7\u5411GLPG\u652f\u4ed82,000\u4e07\u7f8e\u5143\u7684\u91cc\u7a0b\u7891\u4ed8\u6b3e\u3002<\/p>\n<h2>Biogen\u56de\u8d2d\u80a1\u7968<\/h2>\n<p><a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=BIIB\">Biogen\uff08NASDAQ\uff1aBIIB\uff09<\/a>\u8463\u4e8b\u4f1a\u5df2\u6388\u6743\u56de\u8d2d\u6700\u591a$ 50\u4ebf\u7684\u6d41\u901a\u5728\u5916\u666e\u901a\u80a1\u3002Biogen\u80a1\u4ef7\u6570\u5c0f\u65f6\u540e\u4e0a\u6da81%\u3002<\/p>\n<h2>\u52a0\u62ff\u5927\u9650\u5236\u7535\u5b50\u70df\u4ea7\u54c1\u5e7f\u544a<\/h2>\n<p>\u52a0\u62ff\u5927\u536b\u751f\u90e8\u957fPatty Hajdu\u8868\u793a\uff0c\u5b83\u5c06\u53d1\u6325\u66f4\u5927\u7684\u4f5c\u7528\u6765\u4fdd\u62a4\u5e74\u8f7b\u4eba\uff0c\u5e76\u63d0\u51fa\u4e86\u65b0\u7684\u6cd5\u89c4\uff0c\u4ee5\u7981\u6b62\u5728\u5e74\u8f7b\u4eba\u53ef\u4ee5\u770b\u5230\u6216\u542c\u5230\u7535\u5b50\u70df\uff08\u5305\u62ec\u5728\u7ebf\uff09\u7684\u4fc3\u9500\u548c\u5e7f\u544a\u3002<\/p>\n<h2>Hoth Therapeutics\u4e0e\u5a01\u5c14\u5eb7\u5948\u5c14\u533b\u5b66\u9662\u5408\u4f5c<\/h2>\n<p><a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=HOTH\">Hoth Therapeutics\uff08NASDAQ\uff1aHOTH\uff09<\/a>\u5df2\u4e0e\u5a01\u5c14\u5eb7\u5948\u5c14\u533b\u5b66\u9662\u8fbe\u6210\u4e00\u9879\u7814\u7a76\u5408\u4f5c\u534f\u8bae\uff0c\u4ee5\u68c0\u67e5\u89c6\u9ec4\u9178\u4ee3\u8c22\u963b\u65ad\u5242\uff08RAMBA\uff09\u963b\u65ad\u4eba\u89d2\u8d28\u5f62\u6210\u7ec6\u80de\uff0c\u5c0f\u9f20\u76ae\u80a4\u4e2d\u75e4\u75ae\u81f4\u75c5\u57fa\u56e0\u8868\u8fbe\u4ee5\u53ca\u5c0f\u9f20\u81f4\u764c\u4f5c\u7528\u7684\u80fd\u529b\u3002<\/p>\n<p>\u7814\u7a76\u5408\u4f5c\u5c06\u5206\u4e09\u4e2a\u9636\u6bb5\u8fdb\u884c\uff0c\u4e3a\u671f\u4e00\u5e74\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Amgen (NASDAQ:AMGN) has submitted a marketing application to the FDA seeking approval of AMG 798, a biosimilar to Roche&#8217;s (OTCQX:RHHBY) Rituxan (rituximab). ilead Sciences (NASDAQ:GILD) has submitted a marketing application to the FDA seeking approval of filgotinib for patients with moderate-to-severe rheumatoid arthritis.<\/p>\n","protected":false},"author":9,"featured_media":310593,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[427],"tags":[820,455,925,459],"class_list":["post-310597","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-news-zh-hans","tag-820","tag-455","tag-925","tag-459","sectors-life-science-zh-hans","locations-us-zh-hans","exchange-nasdaq-zh-hans","exchange-nyse-zh-hans"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/310597","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=310597"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/310597\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media\/310593"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=310597"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=310597"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=310597"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}